S[ECTION]{.smallcaps} 1 -- Q[UIZ]{.smallcaps} {#sec1-1}
=============================================

Case {#sec2-1}
----

A 53-year-old male is a regular jogger who runs approximately 6 km per day. He had a gradual onset of the right lateral hip pain for 3 months. The pain made him stop jogging 1 month before visiting the clinic of physical medicine and rehabilitation. He received an ultrasound examination for both sides of the hips. A linear transducer was first placed in the horizontal plane on the lateral hip. The ultrasound images on the anterior \[[Figure 1a](#F1){ref-type="fig"}\] and lateral \[[Figure 1b](#F1){ref-type="fig"}\] aspects of the greater trochanter were shown. The transducer was later shifted to a curvilinear type and put along the coronal plane of the lateral hip on the painful \[[Figure 2a](#F2){ref-type="fig"}\] and asymptomatic sides \[[Figure 2b](#F2){ref-type="fig"}\]. The structure indicated by a white arrow appeared to be the lesion.

![(a) We can clearly identify that the gluteus minimus tendon (white arrow head) on the anterior facet of the greater trochanter appears more hypoechoic and thickened than the anterior band of the gluteus medius tendon on the lateral facet. (b) The thickness and echogenicity of anterior and posterior bands of the gluteus medius tendon look similarly normal](JMU-27-58-g001){#F1}

![In the long-axis view (a), the gluteus minimus tendon (white arrow head) at the affected side appears more swollen than that of the contralateral side (black arrow head) (b)](JMU-27-58-g002){#F2}
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